DNA Science for Skin Platform and Repair Damaging Effects of the Sun on the Skin

For more information, please call us at 800-590-4244 or fill out this request form:

Name

Company

Email

Phone

Remergent™ is formulated by AGI Dermatics, the bio-pharmaceutical laboratory that has led the research of DNA repair of the skin for more than 20 years. Founded by Daniel B. Yarosh, PhD, a molecular biologist with a specialty in gene repair, AGI Dermatics specializes in skin photobiology, dedicating research and development to DNA repair, solar impact on the immune system, and cell-signaling in skin.

AGI Dermatics has distinguished itself as the first commercial skincare lab to recognize that DNA damage suppresses the skin's immune function. The company was also the first to demonstrate that DNA repair can preserve and restore healthy skin. Each of these breakthroughs—based on DNA science—is now considered fundamental to the future of genetic dermatology and general skincare.

The company's application of groundbreaking active ingredients and meticulously engineered liposome delivery systems is validated in controlled clinical studies and published in dozens of peer-reviewed scientific and medical journals. Its liposome-delivery systems are the company's core technology and the platform for Remergent products and many of its pharmaceuticals.

Developed to fill critical voids in current skincare therapies, Remergent products activate self-healing, reverse skin cell dysfunction, and maximize results for long term gain through prevention, repair and restoration.

DNA Science for Skin

Built on two decades of scientific research in photobiology and DNA repair, Remergent is the next generation in skincare therapies. Applying biotechnology—in the form of patented liposome delivery systems—to biomimetic and select botanical ingredients, Remergent formulas are uniquely positioned to get active components into skin cells to repair damage, restore healthy response, and resist future injury.